By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioo Scientific and Jungwoo F&B are partnering in an effort to improve methods of cancer diagnosis and treatment, the Austin, Texas-based company said on Monday.

As part of the collaboration Bioo will develop kits for use on Jungwoo's Image Oriented Navigation Laser Microdissection Device imaging platform. Bioo will also develop kits for global microRNA profiling and for protein extraction for peptide analysis of tumor samples using mass spectrometry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.